Education
About Us
Working with TipRanks
Follow Us
Centogene (CNTGF)
OTHER OTC:CNTGF
CNTGF Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.04 - $0.55
Previous CloseN/A
Volume282.00
Average Volume (3M)15.63K
Market Cap
$4.44M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)80.73M
Price to Earnings (P/E)―
Beta0.28
Next Earnings
Sep 03, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding29,000,137
10 Day Avg. Volume39,357
30 Day Avg. Volume15,628
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.00
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Centogene News
PremiumCompany Announcements
Centogene Approves Key Transaction with Charme Capital
PremiumCompany Announcements
Centogene’s Strategic Moves: Sale and Restructuring Plans
PremiumCompany Announcements
Centogene Announces Share Sale to Charme IVPremiumCompany Announcements
Centogene Adjusts Leadership Resignation Dates
PremiumCompany Announcements
Centogene Shifts Ex-CFO to Consultant Role
PremiumCompany Announcements
Centogene Delays Board Members’ Resignation
PremiumCompany Announcements
Centogene Links Gene Mutation to Parkinson’s Disease
PremiumCompany Announcements
Centogene N.V. Seeks New Auditor for 2024Options Prices
Currently, No data available
---
Ownership Overview
―
Insiders
0.61% Other Institutional Investors
99.39% Public Companies and
Individual Investors
CNTGF FAQ
What was Centogene’s price range in the past 12 months?
Centogene lowest stock price was $0.04 and its highest was $0.55 in the past 12 months.
What is Centogene’s market cap?
Centogene’s market cap is $4.44M.
When is Centogene’s upcoming earnings report date?
Centogene’s upcoming earnings report date is Sep 03, 2025 which is in 61 days.
How were Centogene’s earnings last quarter?
Currently, no data Available
Is Centogene overvalued?
According to Wall Street analysts Centogene’s price is currently Overvalued.
Does Centogene pay dividends?
Centogene does not currently pay dividends.
What is Centogene’s EPS estimate?
Centogene’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Centogene have?
Centogene has 29,000,137 shares outstanding.
What happened to Centogene’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Centogene?
Currently, no hedge funds are holding shares in CNTGF
Company Description
Centogene
Centogene (CNTGF) is a global leader in the field of rare disease diagnostics and genetic testing. The company operates within the biotechnology and life sciences sectors, providing comprehensive diagnostic solutions to healthcare providers, pharmaceutical companies, and research institutions. Centogene's core services include genetic testing, biomarker discovery, and data-driven insights, all aimed at improving patient outcomes and advancing precision medicine.
Technical Analysis
Myriad Genetics
―
Qiagen
―
Sarepta Therapeutics
―
Natera
―
Fulgent Genetics
―
Guardant Health
―